Levetiracetam in migraine prophylaxis: a randomized placebo-controlled study in a rural medical institute in northern India. Migraine is often a chronic and disabling disorder. The objective of our study was to assess the efficacy and tolerability of levetiracetam (LEV) in adult migraine prophylaxis.We conducted a prospective, randomized, placebo-controlled study. A total of 65 patients were randomized in a 1:1 ratio to receive LEV (n = 32) or placebo (n = 33).
GlobalResearch at UCSF presents the broad scope of health research that is being conducted by UCSF researchers worldwide